miR-27a as an Oncogenic microRNA of Hepatitis B Virus-related Hepatocellular Carcinoma |
Wu, Xin-Jun
(Department of General Surgery II, The First Affiliated Hospital of Xinxiang Medical University)
Li, Yan (Department of General Surgery II, The First Affiliated Hospital of Xinxiang Medical University) Liu, Dong (Department of Dermatology, The First Affiliated Hospital of Xinxiang Medical University) Zhao, Lun-De (Department of General Surgery II, The First Affiliated Hospital of Xinxiang Medical University) Bai, Bin (Department of General Surgery II, The First Affiliated Hospital of Xinxiang Medical University) Xue, Ming-Hui (Department of General Surgery II, The First Affiliated Hospital of Xinxiang Medical University) |
1 | Ma Y, Yu S, Zhao W, Lu Z, Chen J (2010). miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett, 298, 150-8. DOI ScienceOn |
2 | McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011). Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem, 57, 833-40. DOI ScienceOn |
3 | Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res, 67, 11001-11. DOI ScienceOn |
4 | Mitchell PS, Parkin RK, Kroh EM, et al (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 105, 10513-8. DOI ScienceOn |
5 | Schrauder MG, Strick R, Schulz-Wendtland R, et al (2012). Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One, 7, e29770. DOI |
6 | Szafranska AE, Davison TS, John J, et al (2007). MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene, 26, 4442-52. DOI ScienceOn |
7 | Tinkle CL, Haas-Kogan D (2012). Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics, 6, 207-19. |
8 | Zheng D, Haddadin S, Wang Y, et al (2011). Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol, 4, 575-86. |
9 | Zhou J, Yu L, Gao X, et al (2011). Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol, 29, 4781-8. DOI ScienceOn |
10 | Zinkin NT, Grall F, Bhaskar K, et al (2008). Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res, 14, 470-7. DOI ScienceOn |
11 | Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. DOI ScienceOn |
12 | Brase JC, Johannes M, Schlomm T, et al (2011). Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer, 128, 608-16. DOI ScienceOn |
13 | Budhu A, Jia HL, Forgues M, et al (2008). Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology, 47, 897-907. DOI ScienceOn |
14 | Chen X, Ba Y, Ma L, et al (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 997-1006. DOI ScienceOn |
15 | Chintharlapalli S, Papineni S, Abdelrahim M, et al (2009). Oncogenic microRNA-27a is a target for anticancer agent methyl2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int J Cancer, 125, 1965-74. DOI ScienceOn |
16 | El-Serag HB, Marrero JA, Rudolph L, Reddy KR (2008). Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology, 134, 1752-63. DOI ScienceOn |
17 | Garzon R, Calin GA, Croce CM (2009). MicroRNAs in Cancer. Annu Rev Med, 60, 167-79. DOI ScienceOn |
18 | Gottardo F, Liu CG, Ferracin M, et al (2007). Micro-RNA profiling in kidney and bladder cancers. Urol Oncol, 25, 387-92. DOI ScienceOn |
19 | Guttilla IK, White BA (2009). Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem, 284, 23204-16. DOI ScienceOn |
20 | Huang Z, Huang D, Ni S, et al (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer, 127, 118-26. DOI ScienceOn |
21 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
22 | Ji J, Shi J, Budhu A, et al (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med, 361, 1437-47. DOI ScienceOn |
23 | Ladeiro Y, Couchy G, Balabaud C, et al (2008). MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47, 1955-63. DOI ScienceOn |
24 | Jiang J, Gusev Y, Aderca I, et al (2008). Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res, 14, 419-27. DOI ScienceOn |
25 | Kasinski AL, Slack FJ (2011). MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nature Reviews Cancer, 11, 849-64. DOI ScienceOn |
26 | Kutay H, Bai S, Datta J, et al (2006). Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem, 99, 671-8. DOI ScienceOn |
27 | Lerner M, Lundgren J, Akhoondi S, et al (2011). MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle, 10, 2172-83. DOI |
28 | Li LM, Hu ZB, Zhou ZX, et al (2010). Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res, 70, 9798-807. DOI |
29 | Liu H, Zhu L, Liu B, et al (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett, 316, 196-203. DOI ScienceOn |
30 | Liu T, Tang H, Lang Y, Liu M, Li X (2009). MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett, 273, 233-42. DOI ScienceOn |
31 | Li W, Xie L, He X, et al (2008). Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer, 123, 1616-22. DOI ScienceOn |
32 | Li Z, Hu S, Wang J, et al (2010). MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol, 119, 125-30. DOI ScienceOn |